New Horizon Health Limited
HKEX:6606.HK
14.14 (HKD) • At close July 23, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2020 Q4 | 2020 Q3 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 411.338 | 411.338 | 269.654 | 269.654 | 112.826 | 35.258 | 24.783 | 22.835 |
| Cost of Revenue
| 37.587 | 37.587 | 39.113 | 39.113 | 20.282 | 14.544 | 10.492 | 9.282 |
| Gross Profit
| 373.751 | 373.751 | 230.541 | 230.541 | 92.544 | 20.714 | 14.291 | 13.553 |
| Gross Profit Ratio
| 0.909 | 0.909 | 0.855 | 0.855 | 0.82 | 0.587 | 0.577 | 0.594 |
| Reseach & Development Expenses
| 37.377 | 37.377 | 26.844 | 26.844 | 20.456 | 7.977 | 6.887 | 9.092 |
| General & Administrative Expenses
| 65.37 | 65.37 | 50.219 | 50.219 | 29.578 | 67.75 | -1.346 | 4.112 |
| Selling & Marketing Expenses
| 287.035 | 287.035 | 179.046 | 179.046 | 98.494 | 26.885 | 17.326 | 38.96 |
| SG&A
| 363.28 | 363.28 | 236.163 | 236.163 | 131.887 | 94.635 | 15.98 | 43.072 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | -35.778 | 34.616 | 12.198 |
| Operating Expenses
| 364.924 | 364.924 | 242.078 | 242.078 | 123.416 | 66.834 | 57.483 | 64.362 |
| Operating Income
| -26.906 | -26.906 | -32.466 | -32.466 | -59.799 | -249.42 | 28.409 | -43.676 |
| Operating Income Ratio
| -0.065 | -0.065 | -0.12 | -0.12 | -0.53 | -7.074 | 1.146 | -1.913 |
| Total Other Income Expenses Net
| 32.888 | 32.888 | 25.263 | 25.263 | 27.173 | -5.516 | -9.131 | -0.186 |
| Income Before Tax
| 5.983 | 5.983 | -7.203 | -7.203 | -32.626 | -254.936 | 19.278 | -43.862 |
| Income Before Tax Ratio
| 0.015 | 0.015 | -0.027 | -0.027 | -0.289 | -7.231 | 0.778 | -1.921 |
| Income Tax Expense
| 56.689 | 56.689 | 0.313 | 0.313 | 0.015 | 0.027 | 0.09 | 0.095 |
| Net Income
| 62.827 | 62.827 | -6.978 | -6.978 | -32.641 | -254.963 | 19.188 | -43.957 |
| Net Income Ratio
| 0.153 | 0.153 | -0.026 | -0.026 | -0.289 | -7.231 | 0.774 | -1.925 |
| EPS
| 0.13 | 0.13 | -0.02 | -0.02 | -0.077 | -0.61 | 0.046 | -0.11 |
| EPS Diluted
| 0.13 | 0.13 | -0.017 | -0.017 | -0.077 | -0.61 | 0.046 | -0.11 |
| EBITDA
| -18.24 | -18.24 | -32.289 | -32.289 | -53.731 | -244.991 | 28.409 | -39.326 |
| EBITDA Ratio
| -0.044 | -0.044 | -0.12 | -0.12 | -0.476 | -6.949 | 1.146 | -1.722 |